trial · primary record
Psilocybin
Depression, Anxiety
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 48 |
| Primary completion | 2026-12-31 |
| Primary endpoint | Safety and adverse events (AEs) |
| Registry ID | NCT06200155 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:34.521Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06200155
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Psilocybin · compound